Restored archive. The original History Commons is no longer online; this is a read-only edition of its timelines. Content is licensed CC BY-NC-SA.

March 9, 2000: Merck Scientist Notes that Anticipated Heart Problems Among Vioxx Users Are a ‘Shame’

2000-03-09

Edward Scolnick, head of Merck’s research labs, sends an e-mail to his colleagues noting that Vioxx’s anticipated cardiovascular side effects “are clearly there… It is a shame but it is a low incidence and it is mechanism based as we worried that it was.” [Wall Street Journal, 11/1/2004; HeartWire, 11/1/2004]